Science and the administration of phenylbutazone.

The research article explores the controversy and implications surrounding the use of the drug phenylbutazone in treating horses, particularly those participating in competitive events. It dives deeper into the pharmacological action of the drug, its effects, and potential benefits or drawbacks.

Topic of Controversy

• The article begins by addressing a controversy in the field of veterinary medicine regarding the use of phenylbutazone on horses. This drug is one of many non-steroidal anti-inflammatory drugs being debated for use in equine health, extending to antibiotics, tranquillizers and cardiovascular-active agents.
• There are arguments both for and against its use. Some argue that using drugs to suppress pain or mask physical ailments can harm the horse, while others claim that these drugs can allow a horse to work and provide benefits.
• The article highlights a decision by the Federation Equestre Internationale that approves of controlled phenylbutazone use in competing horses, which has emphasized the ongoing dispute on this issue.

Pharmacological Action of Phenylbutazone

• Next, the article dives into the details of the pharmacological effects of phenylbutazone. The drug, derived from aminopyrine, has been effective in treating rheumatoid and related disorders in people since 1949, primarily due to its metabolite oxyphenbutazone.
• Its analgesic effect and weak antipyretic action result mainly from the local anti-inflammatory action of the drug. The drug is believed to inhibit prostaglandin production from arachidonic acid. Prostaglandins, specifically the E series, are responsible for key signs of inflammation like heat, redness, swelling, pain, and impaired function.

Side Effects

• The article notes that prostaglandin production occurs whenever an injury happens within a joint, and in many other sites including normal reparative cell turnover in the alimentary tract.
• The inhibition of prostaglandin production in such sites by anti-inflammatory drugs, including phenylbutazone, could be the mechanism behind the major toxic effects observed with the use of these compounds.

Implication and Conclusion

• Regardless of the differing views on the use of any particular drug in equine medicine, the article underscores that it is a professional obligation to procure objective data to make informed decisions.
• Acknowledging that a lack of knowledge regarding many therapeutic agents exists, it asserts that such controversies should prompt investigation and research. This proves ultimately beneficial to the horse’s welfare and improves the competence of the clinician.